Glimepiride Tablet
Product Images NDC 68084-788

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 68084-788). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 mg Blister

1 mg Blister
Packaging label for Glimepiride tablet, USP 1 mg, oral tablet in a human prescription drug format. The label indicates the dosage strength of 1 mg and states 'ONCE A DAY'. It includes lot number and expiry date fields, a barcode, and is labeled by American Health Packaging, Columbiana, OH 44427. The label appears in three perforated sections, each identical.*
FDA Label Image

1 mg Carton

1 mg Carton
Label for Glimepiride 1 mg tablets, USP, oral dosage form by American Health Packaging. The label indicates 30 tablets per package, with instruction to take once a day. It includes storage guidance, safety warnings, and notes that the product is distributed by American Health Packaging in Columbus, Ohio, with drug product sourced from Dr. Reddy's Laboratories.*
FDA Label Image

2 mg Blister

2 mg Blister
Sheet of multiple Glimepiride 2 mg tablets packaging labels, each marked as once a day oral tablets. Labels feature dosage strength (2 mg), drug name, UPC barcode, lot number, expiration date, and American Health Packaging as the labeler, located in Columbus, Ohio.*
FDA Label Image

2 mg Carton

2 mg Carton
Label for Glimepiride Tablets, USP 2 mg, oral tablets in a 100-count package (10 x 10 tablets) from American Health Packaging. The label includes dosage strength, NDC 68084-326-01, storage instructions, prescription-only status, and distributor information.*
FDA Label Image

4 mg Blister

4 mg Blister
Glimepiride 4 mg oral tablets from American Health Packaging. The label states the product is a Human Prescription Drug, taken once a day. Each label includes the lot number 123456 and expiration date 02/16, along with barcodes and manufacturing details for Columbia, OH.*
FDA Label Image

4 mg Carton

4 mg Carton
Label for Glimepiride tablets USP, 4 mg strength, by American Health Packaging. The label indicates a quantity of 100 tablets (10 x 10) with instructions for once daily use. It includes storage information and safety warnings about keeping out of reach of children and not using if the blister is damaged. The product is a prescription drug, distributed by American Health Packaging, Columbus, Ohio.*
FDA Label Image

Ahp32601

Ahp32601
Glimepiride 2 mg oral tablet, oval and green, imprinted with "RDY" on one side and "3 | 21" divided by a score line on the other side. Manufactured by American Health Packaging.*
FDA Label Image

Ahp32701

Ahp32701
Glimepiride 2 mg oral tablet, blue, oval-shaped with imprint "RDY" on one side and "3 22" on the other side. This medication is manufactured by American Health Packaging.*
FDA Label Image

Ahp78825

Ahp78825
Glimepiride 2 mg oral tablet shown with an oblong shape and reddish color. One side is imprinted with 'RDY' and the other side with '3 | 20'. This tablet is part of the American Health Packaging label set for Glimepiride in varying strengths.*
FDA Label Image

Structure

Structure
Chemical structure of glimepiride, a sulfonylurea class antidiabetic medication. The diagram shows the molecular connections including a cyclohexyl group, a sulfonylurea moiety, and a pyrrole ring with attached methyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.